IP Library Granted Patent US 12,227,799
Granted Patent B2
US 12,227,799 · App. 17/542,343 · Granted Feb 18, 2025

Compositions and methods for nucleic acid sequencing

Inventors: Eli N. Glezer (Del Mar, CA); Mohammad Vatankhah Varnosfaderani (San Marcos, CA); Daan Witters (San Diego, CA); Vahid Karimkhani (San Diego, CA)
Assignee: Singular Genomics Systems, Inc.
C12Q1/6869C12Q1/6844C12Q1/6874G01N33/5308G01N33/544C12Q2533/101C12Q2565/601
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,227,799
App. No.
17/542,343
Filed
Dec 3, 2021
Granted
Feb 18, 2025
Kind
B2
Art Unit
1683
USPC
435/476
Abstract

Provided herein are methods and compositions for improved sequencing techniques using, for example, polymeric particles and/or three-dimensional structures.

Claims (26)

1. A method of sequencing target polynucleotides in a polymer scaffold comprising polynucleotide primers, wherein said polynucleotide primers are covalently attached to the polymer scaffold, the method comprising:

(a) amplifying the target polynucleotides to produce discrete amplicon clusters within the polymer scaffold,

wherein amplifying comprises rolling circle amplification the amplicon clusters are arranged at a plurality of depths; and

(b) sequencing the amplicon clusters, wherein sequencing comprises detecting sequences of signals within the polymer scaffold at a first depth and a second depth.

2. The method of claim 1 , wherein the amplicon clusters have a mean or median separation from one another of about 500-5000 nm.

3. The method of claim 1 , wherein the amplicon clusters have a mean or median diameter of about 100-2000 nm, or about 200-1000 nm.

4. The method of claim 1 , wherein the scaffold polymer comprises water, and optionally wherein the scaffold polymer has a refractive index of about 1.3 when hydrated.

5. The method of claim 1 , wherein the scaffold polymer is a hydrogel.

6. The method of claim 1 , wherein step (a) further comprises contacting the polymer scaffold with one or more reagents for amplifying the target polynucleotides.

7. The method of claim 1 , wherein the sequencing of step (b) comprises (i) extending a sequencing primer to incorporate a detectable label that indicates the identity of a nucleotide in the target polynucleotide, (ii) detecting the detectable label, and (iii) repeating the extending and detecting of steps (i) and (ii).

8. The method of claim 1 , wherein the polymer scaffold is formed by a process comprising:

(a) forming an emulsion of oil droplets in a hydrophilic continuous phase, wherein the hydrophilic continuous phase comprises one or more monomers;

(b) polymerizing the one or more monomers to form the polymer scaffold; and

(c) removing the oil to form a plurality of interconnected pores in the polymer scaffold.

9. The method of claim 1 , wherein the first depth and second depth are separated by 0.1-10 microns.

10. The method of claim 1 , wherein the target polynucleotides are circular.

11. The method of claim 1 , further comprising detecting sequences of signals within the polymer scaffold at a plurality of depths.

12. The method of claim 1 , wherein the polymer scaffold is permeable to a polymerase.

13. The method of claim 1 , wherein the sequencing of step (b) comprises a sequencing-by-synthesis (SBS) process.

14. The method of claim 1 , wherein amplifying the target polynucleotides comprises bridge amplification or an isothermal amplification reaction.

15. The method of claim 1 , wherein the target polynucleotide comprises a primer binding sequence.

16. The method of claim 1 , wherein the polymer scaffold comprises a polymer of one or more of GMA (glicydyl methacrylate), HEMA (hydroxyethylmethacrylate), HEA (hydroxyethylacrylate), HPMA (hydroxypropylmethacrylate), polyacrylamide, poly-N-isopropylacrylamide, poly N-isopropylpolyacrylamide, 2-hydroxyethyl acrylate, polyethylene glycol acrylate, and polyethylene glycol methacrylate, or a copolymer thereof.

17. The method of claim 1 , wherein the polymer scaffold is attached to a glass surface.

18. The method of claim 1 , wherein the polymer scaffold is in a channel of a flow cell.

19. The method of claim 1 , wherein sequencing comprises detecting a series of fluorescent emissions in a first xy plane at the first depth and a series of fluorescent emissions in a second xy plane at the second depth.

20. The method of claim 1 , wherein the first depth and a second depth are separated by greater than 500 nm.

Assignments (2)
SECURITY INTEREST Recorded Mar 7, 2025
From: SINGULAR GENOMICS SYSTEMS, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 070440/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2022
From: GLEZER, ELI N.; VARNOSFADERANI, MOHAMMAD VATANKHAH; WITTERS, DAAN; KARIMKHANI, VAHID
To: SINGULAR GENOMICS SYSTEMS, INC
Reel/Frame 061168/0008 →
Continuity (4)
Continuation 17030886 · Sep 24, 2020
Continuation PCTUS2020017060 · Feb 6, 2020
Provisional Application 62802062 · Feb 6, 2019
Related Publication 20220154271A1 · May 19, 2022
References Cited (34)
US 5034506A · Summerton · 1991 [cited by applicant]
US 5235033A · Summerton et al. · 1993 [cited by applicant]
US 7057026B2 · Barnes et al. · 2006 [cited by applicant]
US 7541444B2 · Milton et al. · 2009 [cited by applicant]
US 8003354B2 · Shen et al. · 2011 [cited by applicant]
US 8178360B2 · Barnes et al. · 2012 [cited by applicant]
US 11236387B2 · Glezer · 2022 [cited by examiner]
US 11434525B2 · Glezer · 2022 [cited by applicant]
US 12060605B2 · Glezer · 2024 [cited by examiner]
US 20040096960A1 · Mehta · 2004 [cited by applicant]
US 20070087362A1 · Church et al. · 2007 [cited by applicant]
US 20070141340A1 · Song · 2007 [cited by applicant]
US 20080242560A1 · Gunderson et al. · 2008 [cited by applicant]
US 20090253220A1 · Banerjee · 2009 [cited by applicant]
US 20110244048A1 · Amiji et al. · 2011 [cited by applicant]
US 20120301926A1 · Chen et al. · 2012 [cited by applicant]
US 20120309651A1 · Pregibon et al. · 2012 [cited by applicant]
US 20140080717A1 · Li et al. · 2014 [cited by applicant]
US 20160024555A1 · Church et al. · 2016 [cited by applicant]
US 20180016634A1 · Hindson et al. · 2018 [cited by applicant]
US 20180119220A1 · Grass et al. · 2018 [cited by applicant]
US 20190241950A1 · Daugharthy et al. · 2019 [cited by applicant]
US 20200071751A1 · Daugharthy et al. · 2020 [cited by applicant]
US 20200354774A1 · Church et al. · 2020 [cited by applicant]
WO WO2014085603 · 2014 [cited by applicant]
WO WO2017079406 · 2017 [cited by applicant]
WO WO2020076979 · 2020 [cited by applicant]
WO WO2020163630 · 2020 [cited by applicant]
Flot et al., Contact genomics: Scaffolding and Phasing (meta)genomes using chromosome 3D physical signatures, Febs Leetters., 589 (2015) 2966-2974 (Year: 2015). [cited by examiner]
Gan, Z. et al. (May 13, 2016). “Biomimetic gyroid nanostructures exceeding their natural origins,” Sci Adv 2(5):e:1600084. [cited by applicant]
Wikipedia (Dec. 23, 2018). “Illumina Dye Sequencing,”located at https://en.wikipedia.org/wiki/Illumina_dye_sequencing, 6 pages. [cited by applicant]
Written Opinion mailed on Jul. 20, 2020 for PCT Application No. PCT/US2020/017060, filed Feb. 6, 2020, 10 pages. [cited by applicant]
International Search Report mailed on Jul. 20, 2020 for PCT Application No. PCT/US2020/017060, filed Feb. 6, 2020, 5 pages. [cited by applicant]
Partial European Search Report mailed on Oct. 6, 2022, for EP Patent Application No. 20752608.8, 19 pages. [cited by applicant]
Cited By (2)
US 12,460,261 US 12,680,133